Mutations in either ECHA or ECHB result in metabolic diseases of mTFP deficiency21,27–29, and defects of ECHA result in long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (LCHAD)30,31. Here, HADHA is linked to metabolic disease.